QNRX — QUOIN PHARMACEUTICALS LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 20 SEC-registered investment managers reported holding QNRX (QUOIN PHARMACEUTICALS LTD) in their latest 13F filings, with a combined reported value of $6.83M across 1.41M shares. That is +19.5% by share count (+228.27K shares) versus the previous quarter, while reported value moved -12.3%. Ownership is concentrated: the five largest holders account for 60.3% of reported value and the top ten for 88.2%.
Compared with the prior quarter, 1 opened new positions, 10 added to existing stakes, 3 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of QUOIN PHARMACEUTICALS LTD (QNRX) include Stonepine Capital Management, LLC, AIGH Capital Management LLC, Nantahala Capital Management, LLC, ranked by reported 13F value among the 51 institutional holders on this page.
QNRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 13 | 809.39K | $3.69M | +79.3% |
| Q2 2026 | 20 | 1.41M | $6.83M | +19.5% |
| Q1 2026 | 21 | 1.26M | $8.32M | +14.0% |
| Q4 2025 | 19 | 917.64K | $13.24M | +169.2% |
| Q3 2025 | 4 | 1.49K | $10.72K | -7.6% |
| Q2 2025 | 6 | 2.54K | $23.40K | -99.2% |
| Q1 2025 | 10 | 401.63K | $90.22K | +173.2% |
| Q4 2024 | 14 | 1.55M | $1.01M | +87.9% |
Over the 8 quarters shown, institutional share counts decreased 48% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+173.2%).
Top Institutional Holders (Q3 2026) — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 252.43K | $1.15M | 0.88% | Add | |
| 236.23K | $1.08M | 0.11% | Add | |
| 236.23K | $1.08M | 0.05% | New | |
| 50.00K | $228.00K | 0.16% | New | |
| 19.46K | $88.72K | 0.00% | New | |
| 8.00K | $36.48K | 0.00% | Hold | |
| 3.17K | $14.45K | 0.00% | Add | |
| 3.12K | $14.21K | 0.00% | Add | |
| 437 | $2.13K | 0.00% | New | |
| 171 | $780 | 0.00% | New | |
| 128 | $584 | 0.00% | Reduce | |
| 9 | $41 | 0.00% | New | |
| 4 | $18 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 214.99K | $1.04M | 0.82% | Add | |
| 211.54K | $1.02M | 0.16% | Hold | |
| 199.49K | $965.51K | 0.64% | Add | |
| 112.32K | $543.64K | 0.00% | Add | |
| 112.32K | $543.64K | 0.00% | Add | |
| 100.30K | $485.45K | 0.02% | Hold | |
| 76.45K | $370.00K | 0.00% | Reduce | |
| 75.00K | $363.00K | 0.00% | Hold | |
| 72.73K | $352.01K | 0.01% | Hold | |
| 70.00K | $338.80K | 0.02% | Add | |
| 59.84K | $289.62K | 0.01% | Hold | |
| 32.37K | $156.68K | 0.10% | Reduce | |
| 21.47K | $103.91K | 0.00% | Add | |
| 20.00K | $96.80K | 0.04% | Hold | |
| 15.01K | $72.63K | 0.00% | New | |
| 8.00K | $38.72K | 0.00% | Add | |
| 6.77K | $32.78K | 0.00% | Add | |
| 2.33K | $11.28K | 0.00% | Add | |
| 439 | $2.12K | 0.00% | Reduce | |
| 355 | $1.72K | 0.00% | Add |
Q1 2026 — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 211.54K | $1.40M | 0.17% | Hold | |
| 196.59K | $1.30M | 0.87% | New | |
| 100.30K | $661.98K | 0.03% | Add | |
| 84.85K | $560.00K | 0.35% | New | |
| 79.58K | $525.24K | 0.00% | Hold | |
| 76.25K | $503.23K | 0.00% | Add | |
| 76.25K | $503.23K | 0.00% | Add | |
| 75.00K | $495.00K | 0.00% | Hold | |
| 72.73K | $480.02K | 0.02% | Add | |
| 60.00K | $396.00K | 0.01% | Add | |
| 59.84K | $394.93K | 0.01% | Hold | |
| 53.46K | $352.84K | 0.21% | Reduce | |
| 51.00K | $336.60K | 0.05% | Add | |
| 32.52K | $214.62K | 0.00% | New | |
| 20.00K | $132.00K | 0.07% | New | |
| 4.00K | $26.40K | 0.00% | Add | |
| 2.51K | $16.58K | 0.00% | Add | |
| 1.72K | $11.35K | 0.00% | Reduce | |
| 1.52K | $10.03K | 0.00% | Reduce | |
| 1.30K | $8.58K | 0.00% | New | |
| 2 | $13 | 0.00% | Reduce |
Q4 2025 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 211.54K | $3.05M | 0.35% | New | |
| 79.58K | $1.15M | 0.00% | New | |
| 78.19K | $1.13M | 0.87% | New | |
| 75.00K | $1.08M | 0.00% | New | |
| 74.82K | $1.08M | 0.00% | New | |
| 74.82K | $1.08M | 0.00% | New | |
| 64.80K | $934.99K | 0.03% | New | |
| 59.84K | $863.46K | 0.02% | New | |
| 58.23K | $840.26K | 0.07% | New | |
| 49.32K | $711.73K | 0.17% | New | |
| 30.00K | $432.90K | 0.21% | New | |
| 25.00K | $360.75K | 0.01% | New | |
| 17.45K | $251.78K | 0.00% | New | |
| 12.05K | $173.93K | 0.01% | New | |
| 3.00K | $43.29K | 0.00% | New | |
| 2.08K | $30.07K | 0.00% | Add | |
| 1.67K | $24.03K | 0.00% | Add | |
| 247 | $3.56K | 0.00% | Add | |
| 17 | $245 | 0.00% | Add |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.21K | $8.70K | 0.00% | Reduce | |
| 278 | $2.00K | 0.00% | Add | |
| 2 | $14 | 0.00% | Hold | |
| 1 | $7 | 0.00% | Reduce |
Q2 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.24K | $11.45K | 0.00% | Reduce | |
| 717 | $6.62K | 0.00% | Reduce | |
| 240 | $2.21K | 0.00% | New | |
| 206 | $1.90K | 0.00% | Reduce | |
| 130 | $1.20K | 0.00% | Reduce | |
| 2 | $18 | 0.00% | Reduce |
New Positions (Q2 2026)
- XTX Topco Ltd 15.01K sh · $72.63K
Fully Exited (vs previous quarter)
- Centiva Capital, LP sold 60.00K sh · $396.00K
- Citadel Advisors sold 32.52K sh · $214.62K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 252.43K | 199.49K | 53.46K | 78.19K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AIGH Capital Management LLC | 236.23K | 70.00K | 51.00K | 49.32K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 236.23K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 50.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 19.46K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 8.00K | 8.00K | 4.00K | 3.00K | — | 206 | 456 | — | — | — | — | — | — | — | 78 | 79 | — | — | 108.89K |
| RHUMBLINE ADVISERS | 3.17K | 2.33K | 1.52K | 1.67K | 1.21K | 1.24K | 41.74K | 24.13K | 20.79K | 14.79K | 3.80K | 1.06K | 908 | — | — | — | — | — | — |
| GAMMA Investing LLC | 3.12K | 439 | 1.72K | 2.08K | 278 | 240 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 437 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Arax Advisory Partners | 171 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 128 | 355 | 2 | 247 | 2 | 2 | 108 | 24 | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 9 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NISA INVESTMENT ADVISORS, LLC | 4 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Ikarian Capital, LLC | — | 211.54K | 211.54K | 211.54K | — | — | — | 275.00K | — | — | — | — | — | — | — | — | — | — | — |
| Dauntless Investment Group, LLC | — | 214.99K | 196.59K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Woodline Partners LP | — | 76.45K | 79.58K | 79.58K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | — | 75.00K | 75.00K | 75.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Millennium Management | — | 112.32K | 76.25K | 74.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MILLENNIUM MANAGEMENT LLC | — | 112.32K | 76.25K | 74.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SummitTX Capital, L.P. | — | 100.30K | 100.30K | 64.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold QNRX?
As of 2026-Q2, 20 institutional funds reported holding QNRX (QUOIN PHARMACEUTICALS LTD) in SEC 13F filings, with a combined reported value of $6.83M.
How many shares of QNRX do institutions own?
13F filers reported 1.41M shares of QNRX, worth $6.83M in aggregate at the end of 2026-Q2.
Is institutional ownership of QNRX rising or falling?
Share counts moved +19.5% versus the prior quarter — accumulation.
Who are the top institutional holders of QNRX?
The largest 13F holders are Stonepine Capital Management, LLC, AIGH Capital Management LLC, Nantahala Capital Management, LLC, Dauntless Investment Group, LLC, Ikarian Capital, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of QUOIN PHARMACEUTICALS LTD?
The major shareholders of QUOIN PHARMACEUTICALS LTD (QNRX) by reported 13F value are Stonepine Capital Management, LLC, AIGH Capital Management LLC, Nantahala Capital Management, LLC, Dauntless Investment Group, LLC, Ikarian Capital, LLC, among 51 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.